Verition Fund Management LLC Cuts Holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Verition Fund Management LLC trimmed its holdings in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 49.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,007 shares of the semiconductor company’s stock after selling 11,540 shares during the quarter. Verition Fund Management LLC’s holdings in Axcelis Technologies were worth $1,259,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the business. Reinhart Partners LLC. increased its holdings in Axcelis Technologies by 64.1% during the third quarter. Reinhart Partners LLC. now owns 687,608 shares of the semiconductor company’s stock valued at $72,096,000 after buying an additional 268,560 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its holdings in Axcelis Technologies by 12.1% in the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 510,894 shares of the semiconductor company’s stock worth $53,568,000 after purchasing an additional 55,048 shares during the last quarter. Boston Trust Walden Corp purchased a new position in Axcelis Technologies in the third quarter worth $53,099,000. American Century Companies Inc. grew its holdings in Axcelis Technologies by 11.2% in the second quarter. American Century Companies Inc. now owns 385,181 shares of the semiconductor company’s stock worth $54,769,000 after purchasing an additional 38,827 shares during the last quarter. Finally, Paradigm Capital Management Inc. NY grew its holdings in Axcelis Technologies by 5.9% in the second quarter. Paradigm Capital Management Inc. NY now owns 349,200 shares of the semiconductor company’s stock worth $49,653,000 after purchasing an additional 19,400 shares during the last quarter. 89.98% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Benchmark lowered shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Friday, November 8th. Needham & Company LLC reaffirmed a “hold” rating on shares of Axcelis Technologies in a report on Friday, November 8th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Axcelis Technologies has an average rating of “Moderate Buy” and a consensus price target of $167.33.

Axcelis Technologies Trading Up 0.9 %

NASDAQ:ACLS opened at $74.19 on Friday. The company has a market capitalization of $2.41 billion, a P/E ratio of 10.97, a PEG ratio of 2.37 and a beta of 1.53. The firm has a fifty day simple moving average of $86.54 and a 200-day simple moving average of $108.55. The company has a current ratio of 4.45, a quick ratio of 3.29 and a debt-to-equity ratio of 0.04. Axcelis Technologies, Inc. has a 12 month low of $69.35 and a 12 month high of $158.61.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.